Elnora AI

Elnora is an AI agent purpose-built for biomedical laboratory protocol generation and optimization. Designed for biotech and pharma teams, Elnora drafts, refines, and continuously improves lab protocols by learning from every experiment run — including failures — turning what is typically discarded negative data into actionable intelligence that makes future protocols smarter and more reliable.

At its core, Elnora operates through a natural language interface, allowing scientists to describe what they need in plain language and receive complete, ready-to-use lab protocols in return. Whether the work involves cell culture, assay development, CRISPR workflows, or other biomedical procedures, Elnora handles the complexity of protocol drafting so researchers can focus on science.

Core Capabilities

• Protocol Generation: Elnora drafts complete lab protocols from natural language descriptions, covering a wide range of biomedical workflows including cell culture, assay development, and CRISPR-based experiments.
• Learning from Failures: Unlike traditional approaches where negative data is discarded, Elnora treats every experiment — successful or failed — as a learning opportunity, continuously improving the quality and accuracy of future protocols based on accumulated experimental outcomes.
• Broad Integrations: Elnora connects to widely used life sciences platforms including Benchling and Signals, as well as collaboration tools like Slack, and any system that exposes a REST API, enabling seamless fit into existing laboratory workflows.

Technical Architecture

• Connect Layer: Elnora uses the Model Context Protocol (MCP) and API connectivity to integrate with external tools and data sources.
• Think Layer: Elnora leverages graphs and contextual reasoning to understand experimental history and inform protocol recommendations.
• Execute Layer: Elnora acts through skills, tools, and code execution, enabling it to carry out tasks autonomously within the lab informatics ecosystem.

Elnora is built for biotech and pharma teams seeking to accelerate experimental workflows, reduce protocol errors, and systematically capture institutional knowledge — including the lessons embedded in failed experiments.